Guacetisal
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
| Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.054.221 |
| Chemical and physical data | |
| Formula | C16H14O5 |
| Molar mass | 286.283 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
| |
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases. Chemically, it is an ester resulting from the combination of aspirin and guaiacol.
|
pyrazolones / pyrazolidines |
|
|---|---|
| salicylates | |
|
acetic acid derivatives and related substances |
|
| oxicams | |
|
propionic acid derivatives (profens) |
|
|
n-arylanthranilic acids (fenamates) |
|
|
COX-2 inhibitors (coxibs) |
|
| other | |
| NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |